J&J Units Lodge IP Suit Over Generic Concerta
Two Johnson & Johnson units sued a Hungarian pharmaceutical company in Illinois federal court Wednesday, aiming to block the drugmaker from launching a generic version of the attention deficit hyperactivity disorder...To view the full article, register now.
Already a subscriber? Click here to view full article